Skip to main content

Cornell University

PORTENT

A Center for Point of Care Technologies for Nutrition, Infection and Cancer

PORTENT 2026 Technology Showcase

July 9, 2026 | 5:00-6:00 PM

Griffis Faculty Club, New York City

The PORTENT 2026 Technology Showcase will bring together our current PORTENT performer teams along with a select group of companies from the New York City/ Cornell ecosystem developing promising point-of-care diagnostics, digital health tools, clinical screening technologies, monitoring platforms, and related medical technologies. Join us to connect with startups, investors, industry partners, clinicians, researchers, students, commercialization experts, and others interested in advancing point-of-care health technologies. Register here


PORTENT translates breakthrough point-of-care diagnostics into rapid, affordable tests that reduce the burden of chronic disease, curb infectious threats, and strengthen prevention efforts across the United States. By integrating technology development with clinical validation, training, and lab-to-market programs, PORTENT accelerates earlier detection of conditions – from diabetes, heart disease to emerging infections – so providers can intervene sooner, patients stay healthier, and health care costs decline.




PORTENT backs five new technologies to expand access to care 
April 10, 2026
Five next-generation point-of-care technologies have been selected for funding by PORTENT, a Center for Point-of-Care Technologies for Nutrition, Infection, and Cancer at Cornell, focusing on developing enhanced diagnostics, and aimed at reducing delays and improving access for crucial healthcare across the globe…READ MORE


Unsplash image of tuberculosis bacteria

Cornell researchers awarded grant to advance tuberculosis diagnostics
December 1, 2025
A project led by Cornell’s Center for Point of Care Technologies for Nutrition, Infection and Cancer (PORTENT) to develop a low-cost, battery-powered device for sample preparation in tuberculosis (TB) testing in areas with limited lab access and infrastructure, has received a $250,000 grant from the Gates Foundation….READ MORE